What is the dosing range for DSIP?

DSIP is typically dosed at 100mcg (low), 200mcg (moderate), or 500mcg (high) mcg, administered Once daily (evening) or every other day. These ranges are aggregated from preclinical research and community protocols — not medical dosing guidance.

What are the reported side effects of DSIP?

Reported side effects of DSIP include: Generally well-tolerated, Daytime drowsiness if dosed in morning, Mild headache, Altered dream quality (common), Transient nausea (rare).

Nootropic

DSIP

Also known as: Delta Sleep Inducing Peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

DSIP is a research compound not approved for human use. For informational purposes only.

📚 Content aggregated from:3 peer-reviewed sources·r/Peptides community·PubMed / NCBI

Overview

DSIP (Delta Sleep Inducing Peptide) is a nonapeptide (9 amino acids) first isolated from rabbit thalamus in 1974, initially believed to directly induce slow-wave (delta) sleep. Research has since broadened its profile considerably: it modulates the HPA axis (reducing stress-driven cortisol), influences GH and LH release, demonstrates antioxidant properties, and may have cardioprotective effects. Despite decades of research, its precise receptor system remains incompletely characterized.

Research Summary

DSIP does not directly trigger sleep in the simple sense originally proposed — more recent research indicates it modulates the neuroendocrine environment that facilitates sleep. Key findings: it reduces ACTH-driven cortisol elevation under stress, increases GH secretion in some models, and attenuates withdrawal severity in opioid and alcohol dependence (mechanisms unclear). DSIP demonstrates antioxidant effects and has cardioprotective properties in ischemic preconditioning models in animals. Its unique resistance to most peptidases (attributed to its unusual conformation) gives it a relatively long half-life for a nonapeptide.

Dosing Range

low

100mcg

moderate

200mcg

high

500mcg

Units: mcg · Frequency: Once daily (evening) or every other day

Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.

Administration Routes

Subcutaneous injectionIntranasalIntravenous (clinical studies)

Reconstitution Notes

Reconstitute with bacteriostatic water to 1mg/mL. Stable 28 days refrigerated. Can be used intranasally at 0.1mg/mL. Evening administration preferred for sleep-related use; morning for HPA axis/cortisol applications.

Step-by-step reconstitution guide →

Supplies you'll need

Insulin Syringes (U-100)Reconstitution Needles Lambda BAC Water Alcohol Prep Pads

Affiliate links — Research Stack may earn a small commission at no extra cost to you.

Reported Side Effects

Generally well-tolerated
Daytime drowsiness if dosed in morning
Mild headache
Altered dream quality (common)
Transient nausea (rare)

Research Papers

3 peer-reviewed sources

DSIP: A sleep-modulating peptide — isolation, synthesis, and biological activity

European Journal of Biochemistry1980

Delta sleep-inducing peptide modulates corticotropin-releasing factor and cortisol responses to stress

Neuroendocrinology1988

DSIP — an update on its biochemical, physiological, and pharmacological properties

Progress in Neurobiology1986

Community Experiences

Aggregated from public forums. Anecdotal — not clinical evidence.

r/Peptides

Community reports on DSIP for sleep quality, stress resilience, and cortisol management.

View original thread

r/nootropics

Nootropics community protocols with DSIP — dosing, sleep stack combinations, and cortisol reduction use cases.

View original thread

Overview

DSIP was named for what researchers thought was its primary function — inducing the slow delta waves of deep sleep. Half a century of subsequent research has revealed a more complex picture: DSIP is better understood as a stress-modulating neuropeptide that creates the neurochemical conditions conducive to sleep and recovery, rather than a direct hypnotic agent.

The HPA Axis Connection

One of DSIP's most reliably documented effects is modulation of the hypothalamic-pituitary-adrenal (HPA) axis — the cortisol/stress response system. Under stress conditions, DSIP:

Attenuates ACTH-driven cortisol elevation
Reduces the amplitude of stress-induced cortisol peaks
Normalizes the cortisol awakening response

This HPA dampening is likely the primary mechanism behind DSIP's sleep-facilitating effects: high cortisol (especially evening cortisol) is one of the main disruptions to sleep onset and sleep architecture.

Sleep Architecture Effects

DSIP's effects on sleep are not sedative — it doesn't cause drowsiness through histamine or GABA blockade. Instead, it appears to:

Increase slow-wave (delta) sleep proportion
Reduce nighttime cortisol-driven arousals
Improve subjective sleep quality without morning grogginess

This makes it attractive for stress-driven insomnia where standard sedatives are too heavy-handed.

Withdrawal Attenuation

One of the more interesting findings in DSIP research is its ability to reduce severity of withdrawal symptoms in opioid and alcohol dependence models. The mechanism is unclear but may relate to HPA normalization — withdrawal from both substances involves extreme HPA hyperactivation. DSIP's dampening of this stress axis may reduce the physiological distress component of withdrawal.

Unique Stability

Most nonapeptides are rapidly degraded in plasma. DSIP's unusual tertiary structure — it forms an irregular conformation rather than a standard helix or sheet — makes it resistant to many common peptidases. This gives it an extended effective half-life relative to its size.

Sleep Stack Combinations

Common research stacks for sleep optimization:

DSIP + Pinealon: HPA modulation + pineal/melatonin support
DSIP + Semax/Selank (taken AM): Daytime stress resilience → better nighttime recovery
DSIP + GH peptides (pre-sleep): DSIP cortisol reduction + GH pulse for maximum recovery